Skip to content
10-Q

Quarterly Report

Surgery Partners, Inc. SGRY

0001638833-26-000046

← back to feed
Filed
May 5, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · Apr 28, 2026 130.79M sh
Shares Diluted Q1 2026 · Mar 31, 2026 128.37M sh
Shares Diluted Q1 2026 · Mar 31, 2025 126.6M sh
Capex Q1 2026 · Mar 31, 2026 $16M
Capex Q1 2026 · Mar 31, 2025 $22.7M
Operating Cash Flow Q1 2026 · Mar 31, 2026 $11.7M
Operating Cash Flow Q1 2026 · Mar 31, 2025 $6M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $182.3M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $239.9M
Stockholders Equity Q1 2026 · Mar 31, 2026 $1.69B
Stockholders Equity Q1 2026 · Dec 31, 2025 $1.71B
Current Liabilities Q1 2026 · Mar 31, 2026 $581.7M
Current Liabilities Q1 2026 · Dec 31, 2025 $615.5M
Current Assets Q1 2026 · Mar 31, 2026 $1.08B
Current Assets Q1 2026 · Dec 31, 2025 $1.15B
Total Assets Q1 2026 · Mar 31, 2026 $8.04B
Total Assets Q1 2026 · Dec 31, 2025 $8.12B
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.28
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.30
Eps Basic Q1 2026 · Mar 31, 2026 −$0.28
Eps Basic Q1 2026 · Mar 31, 2025 −$0.30
Sga Expense Q1 2026 · Mar 31, 2026 $39.3M
Sga Expense Q1 2026 · Mar 31, 2025 $36M
Net Income Q1 2026 · Mar 31, 2026 −$35.9M
Net Income Q1 2026 · Mar 31, 2025 −$37.7M
Operating Income Q1 2026 · Mar 31, 2026 $65.8M
Operating Income Q1 2026 · Mar 31, 2025 $61.9M